ASSOCIATION OF DYSLIPIDAEMIA AND COMORBIDITIES WITH RISK FACTORS AMONG DIABETIC PATIENTS: A RETROSPECTIVE OBSERVATIONAL ANALYSIS.

Prabhakar Bhushan  Mishra; Rajendra Prasad  Jaiswal; Bharat  Bhushan

doi:10.51168/sjhrafrica.v5i12.1491

Authors

Prabhakar Bhushan Mishra Medical Officer, Department of General Medicine, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India
Rajendra Prasad Jaiswal Medical Officer, Department of General Medicine, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India
Bharat Bhushan Professor, Department of General Medicine, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India

DOI:

https://doi.org/10.51168/sjhrafrica.v5i12.1491

Keywords:

Diabetes mellitus, Dyslipidaemia, Comorbidities, Cholesterol, Hypertension

Abstract

Background

Diabetes mellitus (DM) is a disease marked by hyperglycemia brought on by an imbalance between the action or cooperation of insulin and its secretion.

Aim

To determine how risk variables are related to dyslipidemia and comorbidities in patients with type 2 diabetes mellitus (T2DM).

Materials and Methods

An enrolment of 65 T2DM patients was made using the electronic medical record. The link between the patients' dyslipidemia and current comorbidities and the available laboratory, clinical, and demographic data was looked for. The SPSS-23 software was used for statistical analysis.

Results

Out of the 65 T2DM patients, 19 (29.22%) were male and 46 (70.76%) were female, with a mean age of 60.12±10.49 years, according to the electronic health record. 31 (47.38%) participants had diabetes mellitus for more than ten years, and 44 (68.30%) subjects had poor glycaemic control (HbA1c > 7%). 21 (31.68%) of the participants in this study had hypertension (HTN), 22 (34.45%) had ischemic heart disease (IHD), 9 (13.84%) were obese, 2 (2.45%) had a stroke, and 53(82.76%) had dyslipidemia. Out of the 54 patients with dyslipidemia, 41 (62.44%) were receiving treatment for hypolipidemia.

Conclusion

Findings showed that comorbidities were linked to aging and that HTN, IHD, and dyslipidemia were prevalent comorbidities. The present patterns in T2DM comorbidities and symptomatology were brought to light by this investigation. All of these extremely morbid consequences of this avoidable illness can be avoided with effective management and control by early screening and encouraging patients to lead healthy lifestyles.

Recommendations

To prevent the unintended consequences of cardiovascular disorders, routine blood glucose, and blood lipid monitoring for the early identification of dyslipidemia and placing patients under medical management is recommended.

References

Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047-1053. https://doi.org/10.2337/diacare.27.5.1047

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology. 2009 Mar;5(3):150-9. https://doi.org/10.1038/ncpendmet1066

Roglic G, Varghese C, Cowan M. Global report on diabetes (World Health Organization). WHO library cataloging-in publication data. 2016.

Federation I. D. IDF diabetes atlas ninth. Dunia: IDF. 2019.

Collaboration ERF. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375: 2215-22. https://doi.org/10.1016/S0140-6736(10)60484-9

Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Eng J Med. 2011; 364:829-41. https://doi.org/10.1056/NEJMoa1008862

Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. International journal of environmental research and public health. 2015 Oct;12(10):13455-65. https://doi.org/10.3390/ijerph121013455

Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013 Mar; 73:327-39. https://doi.org/10.1007/s40265-013-0023-5

Hirano T. Pathophysiology of diabetic dyslipidemia. Journal of atherosclerosis and thrombosis. 2018 Sep 1;25(9):771-82. https://doi.org/10.5551/jat.RV17023

Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes therapy. 2016 Jun;7:203-19. https://doi.org/10.1007/s13300-016-0167-x

Chakdoufi, S., Moumen, A., & Guerboub, A. (2023). Dyslipidemia and Diabetic Retinopathy in Moroccans Type 2 Diabetics Patients: A Cross-Sectional Study. Journal of Medical Research and Health Sciences, 6(3), 2471-2479. https://doi.org/10.52845/JMRHS/ 2023-6-3-1.

Chaudhury D, Aggarwal A. Diabetic Dyslipidemia: Current Concepts in Pathophysiology and Management. Journal of Clinical & Diagnostic Research. 2018 Jan 1; 12(1). https://doi.org/10.7860/JCDR/2018/29009.11090

Fung AC, Tse G, Cheng HL, et al. Depressive symptoms, co-morbidities, and glycemic control in Hong Kong Chinese elderly patients with type 2 diabetes mellitus. Front Endocrinol. 2018;9:261. https://doi.org/10.3389/fendo.2018.00261

American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care. 2014;37(Suppl 1):S14-S80. https://doi.org/10.2337/dc14-S014

Baranwal JK, Maskey R, Majhi S, et al. Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS. Health Renaiss. 2017;13:16-23. https://doi.org/10.3126/hren.v13i3.17923

Expert Committee on the Prevention and Control of Dyslipidemia in Chinese Adults. Guidelines on prevention and control of dyslipidemia in Chinese adults. Chin J Cardiol. 2007;35:5.

American Diabetes Association. Cardiovascular disease and risk management. Sec. 9 in standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl. 1):S86-S104. https://doi.org/10.2337/dc18-S009

Alshaya AK, Alsayegh AK, Alshaya HK, et al. The common complications and comorbidities among Saudi diabetic patients in Northern Saudi Arabia. Open J Endocr Metab Dis. 2017;7:151-161. https://doi.org/10.4236/ojemd.2017.77014

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62-S69. https://doi.org/10.2337/dc10-S062

Zheng Y, Ley SH, Hu FB. Global etiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88. https://doi.org/10.1038/nrendo.2017.151

Hussain A, Ali I, Ijaz M, et al. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51-57. https://doi.org/10.1177/2042018817692296

Al Zahidy ZA, Baeshen NR, Alzamil FO, et al. Prevalence of diabetes mellitus among patients presented in Endocrinology clinic at King Abdul-Aziz Hospital and Oncology Center - Jeddah - 2014. EC Diabet Metab Res. 2017;1:2-7.

Werfalli M, Kassanjee R, Kalula S, et al. Diabetes in South African older adults: prevalence and impact on quality of life and functional disability-as assessed using SAGE wave 1 data. Glob Health Action. 2018;11:1449924. https://doi.org/10.1080/16549716.2018.1449924

Karlsen B, Rasmussen B, Oftedal B. New possibilities in life with type 2 diabetes: experiences from participating in a guided self-determination Programme in general practice. Nurs Res Prac. 2018;2018. https://doi.org/10.1155/2018/6137628

Boonsatean W, Carlsson A, Östman M, et al. Living with diabetes: experiences of inner and outer sources of beliefs in women with low socioeconomic status. Glob J Health Sci. 2016;8:200. https://doi.org/10.5539/gjhs.v8n8p200

Savonitto S, Morici N, Nozza A, et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes Vascular Dis Res. 2018;15:14-23. https://doi.org/10.1177/1479164117735493

Atif M, Saleem Q, Babar Z-U-D, et al. Association between the vicious cycle of diabetes-associated complications and glycemic control among the elderly: a systematic review. Medicina. 2018;54: E73. https://doi.org/10.3390/medicina54050073

Mosalman Haghighi M, Mavros Y, Fiatarone Singh MA, et al. The effects of structured exercise or lifestyle behavior interventions on long-term physical activity level and health outcomes in individuals with type 2 diabetes: a systematic review, meta-analysis, and meta-regression. J Phys Act Health. 2018; 15:697-707. https://doi.org/10.1123/jpah.2017- 0589